Recent Hires Strengthen Ability to Access Markets and Drive Growth PROVIDENCE, R.I. , Oct.
29, 2024 /PRNewswire/ -- Nabsys 2.0, LLC (Nabsys), a pioneer in electronic nanodetection and developer and manufacturer of the OhmX Analyzer TM , an electronic genome mapping platform for high-resolution structural variant analysis, announces several new hires that provide depth and experience to its commercial and operational leadership. Commercial Leadership Expansion Edd Lee has joined Nabsys as Global Vice President of Sales and Marketing, bringing significant sales and marketing depth to the company's commercial effort.
Edd is a proven leader in the commercial expansion of several established life science and healthcare companies. Edd's experience includes senior marketing, sales, and product management roles at Fabric Genomics, Pacific Biosciences, Illumina Inc., and Roche Diagnostics.
Nabsys will leverage Edd's background in short-read and long-read sequencing technologies to help widen its commercial footprint. Bob Hertsenberg joins Nabsys as Global Head of Instrument Sales, where he will grow Nabsys' direct and indirect sales channels for the OhmXTM Platform. His expertise in sales leadership comes from his role at Bionano Genomics, where he served as the Director of Sales, managing commercial activities in North America and Latin America for their optical genome mapping system.
"The OhmX Platform's breakthrough resolution and cost-efficiency represent a game-changer for genome.